Triple

T5931325
Position Surface form Disambiguated ID Type / Status
Subject Sporothrix E131943 entity
Predicate alternativeTreatment P4714 FINISHED
Object amphotericin B
Amphotericin B is a broad-spectrum antifungal medication primarily used to treat severe, systemic fungal infections.
 E556051 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: amphotericin B | Statement: [Sporothrix, alternativeTreatment, amphotericin B]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: amphotericin B
Context triple: [Sporothrix, alternativeTreatment, amphotericin B]
  • A. rifampicin
    Rifampicin is a broad-spectrum rifamycin antibiotic widely used as a first-line drug in the treatment of tuberculosis and other serious bacterial infections.
  • B. Plaxtol
    Plaxtol is a small rural village and civil parish in Kent, England, known for its historic buildings and surrounding countryside.
  • C. Balemartine
    Balemartine is a small coastal village located on the island of Tiree in Scotland’s Inner Hebrides.
  • D. amantadine
    Amantadine is an antiviral and antiparkinsonian medication used to help manage motor symptoms such as tremor and rigidity in people with Parkinson’s disease.
  • E. Auscitain
    An Auscitain is a resident or native of Auch, a historic town in the Occitanie region of southwestern France.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: amphotericin B
Triple: [Sporothrix, alternativeTreatment, amphotericin B]
Generated description
Amphotericin B is a broad-spectrum antifungal medication primarily used to treat severe, systemic fungal infections.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: amphotericin B
Target entity description: Amphotericin B is a broad-spectrum antifungal medication primarily used to treat severe, systemic fungal infections.
  • A. rifampicin
    Rifampicin is a broad-spectrum rifamycin antibiotic widely used as a first-line drug in the treatment of tuberculosis and other serious bacterial infections.
  • B. Plaxtol
    Plaxtol is a small rural village and civil parish in Kent, England, known for its historic buildings and surrounding countryside.
  • C. Balemartine
    Balemartine is a small coastal village located on the island of Tiree in Scotland’s Inner Hebrides.
  • D. amantadine
    Amantadine is an antiviral and antiparkinsonian medication used to help manage motor symptoms such as tremor and rigidity in people with Parkinson’s disease.
  • E. Auscitain
    An Auscitain is a resident or native of Auch, a historic town in the Occitanie region of southwestern France.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c0085b75e88190a632f9691f9da48b completed March 22, 2026, 3:18 p.m.
NER Named-entity recognition batch_69c049fdb3e08190a72337ab4f48bc8e completed March 22, 2026, 7:58 p.m.
NED1 Entity disambiguation (via context triple) batch_69c0c05eb4b8819097f203e1db94ae8f completed March 23, 2026, 4:23 a.m.
NEDg Description generation batch_69c0c1db6d548190ba4be143aa7c7905 completed March 23, 2026, 4:30 a.m.
NED2 Entity disambiguation (via description) batch_69c0c2bdd44881909aa85589d31e771a completed March 23, 2026, 4:34 a.m.
Created at: March 22, 2026, 4 p.m.